Your browser doesn't support javascript.
loading
Multicentric and collaborative study of Spanish neurosurgical management of pediatric craniopharyngiomas: S-PedCPG.co.
Iglesias, Sara; Munarriz, Pablo M; Saceda, Javier; Catalán-Uribarrena, Gregorio; Miranda, Pablo; Vidal, Juana M; Fustero, David; Giménez-Pando, Jorge; Rius, Francisca.
Afiliación
  • Iglesias S; Neurosurgery Department, Hospital Regional Universitario de Málaga, Málaga, Spain. Electronic address: siglesias95@yahoo.es.
  • Munarriz PM; Neurosurgery Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Saceda J; Neurosurgery Department, Hospital Universitario La Paz, Madrid, Spain.
  • Catalán-Uribarrena G; Neurosurgery Department, Hospital Universitario Cruces, Bilbao, Spain.
  • Miranda P; Neurosurgery Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Vidal JM; Neurosurgery Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Fustero D; Neurosurgery Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Giménez-Pando J; Neurosurgery Department, Hospital Universitario de Badajoz, Badajoz, Spain.
  • Rius F; Statistics Department, Universidad de Málaga, Spain.
Neurocirugia (Astur : Engl Ed) ; 34(2): 67-74, 2023.
Article en En | MEDLINE | ID: mdl-36754754
PURPOSE: To present a descriptive analysis of pediatric craniopharyngiomas (PedCPG) treated in various Spanish hospitals, defining factors related to recurrence and performing a critical analysis of the results. METHODS: We undertook a multicenter retrospective review of PedCPG treated between 2000 and 2017. Data collected included epidemiological variables, clinical and radiological characteristics, goal of first surgery, rate of recurrence and its approach, adjuvant treatment, complications and permanent morbidity. Associations were studied between progression and number of progressions and independent variables. RESULTS: The study involved 69 children from 8 Spanish hospitals. Most of the tumors invaded several intracranial compartments at diagnosis, with the hypothalamus involved in 41.3% of cases. The first treatment strategy was usually gross total resection (GTR) (71%), with some patients treated with radiotherapy or intracystic chemotherapy. The progression rate after first surgery was 53% in a mean follow-up of 88.2 months (range 7-357). In the GTR group 38.8% of tumors recurred, 40% in the group of subtotal resection or biopsy and 93.3% in the cyst fenestration±Ommaya reservoir group. Mortality was 7.2%. Follow-up period, size of the tumor and goal of first surgery were significantly related with progression. CONCLUSIONS: Our results in terms of disease control, hormonal or visual impairment and mortality were acceptable, but there are several areas for improvement. Our short-term goals should be to create a national register of PedCPG, reach a consensus about a treatment algorithm, and improve diagnosis of hypothalamic dysfunction to avoid preventable morbidity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Craneofaringioma Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Child / Humans Idioma: En Revista: Neurocirugia (Astur : Engl Ed) Año: 2023 Tipo del documento: Article Pais de publicación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Craneofaringioma Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Child / Humans Idioma: En Revista: Neurocirugia (Astur : Engl Ed) Año: 2023 Tipo del documento: Article Pais de publicación: España